Evidence map›Paper›PMID 42630925›Full record

ArticleFrontiers in parasitology2026

Differences in novel

Madelaine Usey Talbot, KathyJean Farnam, Jean Saunders, E Brook Goodhew, Gabrielle Smith, Sylvia Ossai, Yong Wang, Sukwan Handali, Isaac O Onkanga, Pauline N Mwinzi and 4 more

Abstract read
In one paragraph

Article in Frontiers in parasitology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Madelaine Usey TalbotLaboratory Leadership Service, Division of Workforce Development, Public Health Infrastructure Center, Centers for Disease Control and Prevention, Atlanta, GA, United States.
KathyJean FarnamDrugs and Diagnostics for Tropical Diseases, San Diego, CA, United States.
Jean SaundersDrugs and Diagnostics for Tropical Diseases, San Diego, CA, United States.
E Brook GoodhewDivision of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Gabrielle SmithDivision of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Sylvia OssaiCDC Foundation, Atlanta, GA, United States.
Yong WangCDC Foundation, Atlanta, GA, United States.
Sukwan HandaliLaboratory Leadership Service, Division of Workforce Development, Public Health Infrastructure Center, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Isaac O OnkangaCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Pauline N MwinziCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Maurice R OdiereCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Matthias SchwarzDrugs and Diagnostics for Tropical Diseases, San Diego, CA, United States.
Marco BiamonteDrugs and Diagnostics for Tropical Diseases, San Diego, CA, United States.
W Evan SecorDivision of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Funding

Bill & Melinda Gates Foundation INV-009170
6 · The paper itself

Abstract

Introduction: Schistosomiasis is a neglected tropical disease caused by parasitic worms of the genus Methods: We evaluated the performance of these RDT prototypes using serum, whole blood, and dried blood spots (DBS). RDT results were determined by two visual readers and a Lumos automated reader, which also provided a quantitative readout of test line intensity. Lumos results were used to quantify test line stability over time. Further, we compared RDT results to other serologic assays (ELISA and the multiplex bead assay) that detect antibodies against Sm25, Sm29 and two additional Results: While both Sm25 and Sm29 RDTs exhibited high specificity and stability that surpassed TPP criteria, their sensitivity fell short of TPP goals. Sensitivity was highest with serum, followed by DBS, then whole blood, which would be the most useful for point-of-care settings. In addition, we identified a gap in the ability of currently used recombinant antigens to detect all people infected with Discussion: Our findings underscore that while these prototypes represent a promising start, there is still a case for novel antigen discovery and generation of RDTs with increased sensitivity to meet TPP criteria.

Indexed as

rapid diagnostic test (RDT)sample matrixSchistosoma mansonischistosomiasisSm25Sm29Target Product Profile (TPP)transmission interruption and surveillance

Identifiers

PMID42630925
PMCPMC13494702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.